{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:21:57Z","timestamp":1785352917486,"version":"3.55.0"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To investigate the effects of posaconazole (POS) and amphotericin B (AMB) combination therapy in cryptococcal infection, we established an experimental model of systemic cryptococcosis in CD1 mice by intravenous injection of three distinct clinical isolates of\n            <jats:italic>Cryptococcus neoformans<\/jats:italic>\n            . Therapy was started 24 h after the infection and continued for 10 consecutive days. POS was given at 3 and 10 mg\/kg of body weight\/day, while AMB was given at 0.3 mg\/kg\/day. Combination therapy consisted of POS given at a low (combo 3) or at a high (combo 10) dose plus AMB. Survival studies showed that combo 3 was significantly more effective than POS at 3 mg\/kg for two isolates tested (\n            <jats:italic>P<\/jats:italic>\n            value, \u22640.001), while combo 10 was significantly more effective than POS at 10 mg\/kg for all three isolates (\n            <jats:italic>P<\/jats:italic>\n            values ranging from &lt;0.001 to 0.005). However, neither combination regimen was more effective than AMB alone. For two isolates, combination therapy was significantly more effective than each single drug at reducing the fungal burden in the brain (\n            <jats:italic>P<\/jats:italic>\n            values ranging from 0.001 to 0.015) but not in the lungs. This study demonstrates that the major impact of POS and AMB combination therapy is on brain fungal burden rather than on survival.\n          <\/jats:p>","DOI":"10.1128\/aac.48.9.3312-3316.2004","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T19:12:57Z","timestamp":1093374777000},"page":"3312-3316","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Posaconazole and Amphotericin B Combination Therapy against\n            <i>Cryptococcus neoformans<\/i>\n            Infection"],"prefix":"10.1128","volume":"48","author":[{"given":"Francesco","family":"Barchiesi","sequence":"first","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Spreghini","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Schimizzi","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Maracci","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Giannini","sequence":"additional","affiliation":[{"name":"Centro di Gestione Presidenza Medicina e Chirurgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Carle","sequence":"additional","affiliation":[{"name":"Centro Interdipartimentale di Epidemiologia, Biostatistica, e Informatica Medica, Universita\u0300 Politecnica delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Scalise","sequence":"additional","affiliation":[{"name":"Istituto di Malattie Infettive e Medicina Pubblica"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0036-46651997000600010","volume":"39","year":"1997","unstructured":"Alves, S. H., J. O. Lopes, J. M. Costa, and C. Klock. 1997. Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS. Rev. Inst. Med. Trop. S\u00e3o Paulo39:359-361.","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"e_1_3_2_3_2","first-page":"1337","volume":"23","year":"1996","unstructured":"Armengou, A., C. Porcar, J. Mascaro, and F. Garcia-Bragado. 1996. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin. Infect. Dis.23:1337-1338.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2435-2441.2000"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1355-1359.2001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010303"},{"key":"e_1_3_2_7_2","first-page":"165","volume":"46","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Update: trends in AIDS incidence. Morb. Mortal. Wkly. Rep.46:165-173.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/149.4.584","volume":"149","year":"1984","unstructured":"Craven, P. C., and J. R. Graybill. 1984. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. J. Infect. Dis.149:584-590.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111230-00026"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinids\/2.4.551","volume":"2","year":"1980","unstructured":"Graybill, J. R., D. M. Williams, E. Van Cutsem, and D. J. Drutz. 1980. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev. Infect. Dis.2:551-558.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.693-715.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2003.08.003","volume":"6","year":"2003","unstructured":"Kontoyiannis, D. P., and R. E. Lewis. 2003. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Res. Updates6:257-269.","journal-title":"Drug Res. Updates"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.985-991.2004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.515"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2473"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.758-764.2004"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.1120"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/146.3.429"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000238524","volume":"33","year":"1987","unstructured":"Polak, A. 1987. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy (Basel)33:381-395.","journal-title":"Chemotherapy (Basel)"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/374850"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/313757"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1345"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/515319"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.598"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.9.3312-3316.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.9.3312-3316.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:44:05Z","timestamp":1645469045000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.9.3312-3316.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1128\/AAC.48.9.3312-3316.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.9.3312-3316.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"2004-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}